Lewis R. Vidler

Lewis R. Vidler

UCB Pharma SA, Brussels - Hanoi / Belgium
Natural Sciences / Chemical Sciences
AD Scientific Index ID: 4423395
-
person_outline Lewis R. Vidler's MOST POPULAR ARTICLES
1-) Druggability analysis and structural classification of bromodomain acetyl-lysine binding sitesLR Vidler, N Brown, S Knapp, S HoelderJournal of medicinal chemistry 55 (17), 7346-7359, 20122892012
2-) Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screeningLR Vidler, P Filippakopoulos, O Fedorov, S Picaud, S Martin, M Tomsett, ...Journal of medicinal chemistry 56 (20), 8073-8088, 20131402013
3-) Structure enabled design of BAZ2-ICR, a chemical probe targeting the bromodomains of BAZ2A and BAZ2BL Drouin, S McGrath, LR Vidler, A Chaikuad, O Monteiro, C Tallant, ...Journal of medicinal chemistry 58 (5), 2553-2559, 20151052015
4-) Epilepsy-associated GRIN2A mutations reduce NMDA receptor trafficking and agonist potency – molecular profiling and functional rescueL Addis, JK Virdee, LR Vidler, DA Collier, DK Pal, D UrsuScientific reports 7 (1), 66, 2017932017
5-) Changing the local coordination environment in mono-and bi-nuclear lanthanide complexes through “click” chemistryM Jauregui, WS Perry, C Allain, LR Vidler, MC Willis, AM Kenwright, ...Dalton transactions, 6283-6285, 2009582009